Osteoporosis - not just a women's issue

There is a widespread belief that the most important risk factors for osteoporosis are gender and age. It turned out, however, that not only women with low estrogen levels, but men with low testosterone levels are at risk for this disease. The disease is. By a decrease in bone density, which often accompanies to fractures and injuries from falls Very good results were obtained with the use of the treatment of male testosterone replacement therapy. However, a prolonged use of testosterone in prostate cancer associated, and elevated levels of red blood cells, while not all the side effects of this treatment is sufficiently explored. Today in the United States diagnosed with osteoporosis, two million women and three million more are at risk, so that the clinical trials of testosterone replacement therapy are urgently needed. They are held in the Department of Internal Medicine at the University of Texas, USA (Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA). The researchers concluded that the dose-weekly administration of testosterone to men over 60 years with hormone levels of low to highly complex shows a positive effect. These studies are an important step in understanding the development process of the treatment of osteoporosis.